Cargando…
Corrigendum to ‘Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis’ [JHEP Reports 3 (2021) 100287]
BACKGROUND & AIMS: Prognostic models of cirrhosis underestimate disease severity for patients with cirrhosis and ascites. Microfibrillar-associated protein 4 (MFAP4) is an extracellular matrix protein linked to hepatic neoangiogenesis and fibrogenesis. We investigated ascites MFAP4 as a predicto...
Autores principales: | Torp, Nikolaj, Israelsen, Mads, Madsen, Bjørn, Lutz, Philipp, Jansen, Christian, Strassburg, Christian, Mortensen, Christian, Knudsen, Anne Wilkens, Sorensen, Grith Lykke, Holmskov, Uffe, Schlosser, Anders, Thiele, Maja, Trebicka, Jonel, Krag, Aleksander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514409/ https://www.ncbi.nlm.nih.gov/pubmed/34693237 http://dx.doi.org/10.1016/j.jhepr.2021.100353 |
Ejemplares similares
-
Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis
por: Torp, Nikolaj, et al.
Publicado: (2021) -
Serum MFAP4, a novel potential biomarker for liver cirrhosis screening, correlates with transient elastography in NAFLD patients
por: Kanaan, Reine, et al.
Publicado: (2023) -
Localization of Microfibrillar-Associated Protein 4 (MFAP4) in Human Tissues: Clinical Evaluation of Serum MFAP4 and Its Association with Various Cardiovascular Conditions
por: Wulf-Johansson, Helle, et al.
Publicado: (2013) -
Evaluation of the biomarker candidate MFAP4 for non-invasive assessment of hepatic fibrosis in hepatitis C patients
por: Bracht, Thilo, et al.
Publicado: (2016) -
Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar‐associated protein 4
por: Madsen, Bjørn S., et al.
Publicado: (2020)